Stimulant use disorder (StimUD) is a substance use disorder involving any of the class of drugs that include cocaine, methamphetamine, and prescription stimulants. Stimulant use is increasing the United States.
According to the most recent data available from the National Survey on Drug Use and Health (NSDUH), in 2022:
- An estimated 4.6 million people aged 12 or older misused prescription stimulants in the past year.
- Young adults aged 18 to 25 continue to have the highest rates of prescription stimulant misuse..
- Approximately 2.8 million people aged 12 or older used methamphetamine in the past year, reflecting a steady increase compared to prior years.
- 1.7 million people aged 12 or older used cocaine in the past year, which shows a slight decline from previous years
Misused Prescription Stimulants in 2022
2000000
Used Methamphetamine in 2022
1000000
Used Cocaine in 2022
0
Stimulant Use Disorder Resources
Websites
Get the facts on Stimulant Use Disorder
Stimulant use disorder (StimUD) is a substance use disorder involving any of the class of drugs that include cocaine, methamphetamine, and prescription stimulants.
U.S. Department of Veterans Affairs: Stimulant Use Disorder
Information on stimulant use disorder from the U.S. Department of Veterans Affairs.
Stimulant Abuse: Signs, Effects, and Treatment Options
This medically reviewed and evidence-based information from American Addiction Centers contains a broad overview of stimulants, including various types and effects, their addictive potential, and treatment options for stimulant misuse.
Good Samaritan Drug Overdose Act of 2015
The Good Samaritan Drug Overdose Act of 2015 (Senate Bill 459, Chapter 26, Statutes of Nevada 2015 NRS 453C.120) created various provisions addressing the opiate overdose epidemic that continues to claim over 300 lives per year in Nevada. The law prevents punitive actions against health professionals and any person who administers naloxone or calls 911 to assist someone who may be overdosing on opiates. It also provides immunity to persons seeking medical treatment for an opioid overdose for themselves or someone else. Learn more about the Good Samaritan Law.
Tools & Resources
SAMHSA’s TIP 33: Treatment for Stimulant Use Disorders
This TIP reviews what is known about treating the medical, psychiatric, and SUD-related problems associated with the use of cocaine and methamphetamine, as well as the misuse of prescription stimulants. The TIP offers recommendations on treatment approaches and maximizing treatment engagement and retention, and strategies for initiating and maintaining abstinence.
SAMHSA’s Evidence-Based Resource Guide Series: Treatment of Stimulant Use Disorders
This guide supports health care providers, systems, and communities seeking to treat stimulant use disorders. It describes relevant research findings, examines emerging and best practices, identifies knowledge gaps and implementation challenges, and offers useful resources.
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder
Developed by ASAM and AAAP, this guideline focuses on the identification, diagnosis, treatment, and promotion of recovery for patients with stimulant use disorder, stimulant intoxication, and stimulant withdrawal.
Centers for Disease Control and Prevention (CDC) Stimulant Guide
This guide will answer some common questions about stimulants, stimulant use, stimulant overdose, and stimulant overdose prevention strategies developed by harm reduction experts. Straightforward and concise answers are provided in an effort to convey the same key information to a variety of audiences. This document does not contain medical advice, nor should it be referred to in case of emergency. It is purely informational.
Posters & Infographics
Stimulant Trifold Brochures
Stimulant Information Brochures for Providers or Consumers help educate on stimulants, including the effects of stimulants use, pregnancy and stimulant use, and treatment options for persons using stimulants.
Download or request free hard copies
Drug Fact Sheet: Stimulants
This fact sheet from the DEA contains information on what stimulants are, common street names, how they are abused, their effect on the body, and their overdose effects.
Download the fact sheet
The face of stimulant addiction: Who uses stimulants? (Infographic)
What does the typical stimulant user look like? In this infographic you can explore the age, gender, past year and past month meth use, polydrug use statistics, and emergency room visits.
View the infographic
Publications
Fast Facts About Substance Use Disorders: What Every Nurse, APRN, and PA Needs to Know (Book)
This resource is the first to provide evidence-based information and strategies for APRNs and PAs who work with individuals with substance use disorders (SUDs). Written in a concise, bulleted style for easy access to critical information, the reference addresses often-undiagnosed medical and psychiatric conditions which may accompany SUDs and the ethical considerations of working with affected patients and families.
Current Diagnosis & Treatment: Psychiatry, 3e: Chapter 51: Stimulant Use Disorders
Leeman RF, Sofuoglu M. Stimulant Use Disorders. In: Ebert MH, Leckman JF, Petrakis IL. eds. Current Diagnosis & Treatment: Psychiatry, 3e. McGraw-Hill Education; 2019. Accessed April 19, 2024. https://accessmedicine.mhmedical.com/content.aspx?bookid=2509§ionid=200980686
Psychiatric Annals: Stimulant Use Disorders
Avellaneda-Ojeda, A., Murtaza, S., Shah, A. A., & Moukaddam, N. (2018). Stimulant use disorders. Psychiatric Annals, 48(8), 372–378. https://doi.org/10.3928/00485713-20180719-02
Frontline: Meth and the Brain
In this audio slideshow, Dr. Rawson explains how meth affects the brain's dopamine receptors, causing the intense pleasure associated with a meth rush and yet eventually making it impossible for the user to experience an pleasure at all. Richard A. Rawson, Ph.D is an Adjunct Associate Professor in the Department of Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine, University of California at Los Angeles.
Webinars & Online Learning
Current News & Research
Project AMPED
This is a multi-year, mixed methods study in Nevada and New Mexico is examining the patterns, reasons for, and health concerns related to methamphetamine use and opioid use.
Reduced drug use is a meaningful treatment outcome for people with stimulant use disorders (January 10, 2024)
NIH-supported findings suggest the need to expand definitions of addiction treatment success beyond abstinence.
Role of natural products in mitigation of toxic effects of methamphetamine: A review of in vitro and in vivo studies
Methamphetamine (METH) increases dopamine, norepinephrine and serotonin concentrations in the synaptic cleft, and induces hyperactivity. The current management of acute METH poisoning relies on supportive care and no specific antidote is available for treatment. The main objective of this review was to present the evidence for effectiveness of the herbal medicine in alleviating the adverse effects of METH abuse.